Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: J Immunol. 2014 Dec 1;194(1):291–306. doi: 10.4049/jimmunol.1401447

Table III.

Changes in microRNA expression in colon during chronic SIV infection.


miRNA ID Chronic SIV (n=12) Uninfected Controls (n=4) Fold
Change
Adjusted
p value

HB31 HB48 GK31 GA19 GH25 FT11 DV42 CP47 HI68 FE53 HG45 HG58 EL66 EH70 EH80 FK25

hsa-miR-181-a* 24.69 23.93 24.36 24.71 24.12 24.72 24.90 25.04 25.62 24.53 24.18 24.98 23.91 23.99 23.72 24.73 −1.5 0.0027
hsa-miR-628-5p 25.93 25.04 25.40 25.51 24.78 24.97 25.08 25.09 25.21 24.99 24.17 25.18 24.10 24.37 24.12 25.10 −1.6 0.0027
hsa-miR-378 25.03 24.87 25.34 25.27 24.65 25.70 25.27 25.76 26.11 24.71 25.07 25.46 24.93 24.87 24.95 25.83 −1.2 0.0174
hsa-miR-424 25.92 25.16 25.54 25.32 25.13 25.27 25.97 25.92 26.52 25.18 26.09 25.92 26.07 26.06 25.84 26.94 1.4 0.0174
hsa-miR-425* 25.22 24.29 24.98 25.06 25.19 25.41 25.44 25.38 25.91 24.68 24.96 25.13 24.44 24.57 24.24 24.97 −1.5 0.0174
hsa-miR-454* 29.52 28.81 29.09 29.78 29.25 29.79 29.77 29.31 29.51 29.21 29.02 29.39 28.23 28.60 28.42 28.97 −1.8 0.0174
hsa-miR-223* 25.99 24.89 25.66 25.48 25.57 24.65 25.35 26.13 26.65 26.33 26.53 26.75 26.54 27.23 26.67 28.97 2.7 0.019
hsa-miR-24-2* 25.36 24.79 25.31 24.98 25.04 24.75 24.92 25.58 25.33 24.98 24.65 25.22 24.51 24.78 24.40 25.18 −1.3 0.019
hsa-miR-520c-3p 32.61 29.79 32.98 31.59 31.06 31.12 31.94 32.16 31.29 31.80 31.35 31.20 30.51 30.43 30.33 31.20 −1.8 0.019
hsa-miR-34a 21.44 20.92 20.74 20.39 19.43 19.67 20.32 21.32 21.14 20.82 19.96 21.01 21.76 21.97 20.97 22.16 2.2 0.0306

hsa-miR-34a* 24.17 23.40 23.32 22.79 22.21 23.14 23.90 24.83 24.38 24.37 23.53 24.67 24.99 25.56 24.60 25.11 2.6 0.0515
hsa-let-7b 18.06 17.44 17.62 17.68 17.00 17.77 17.98 18.00 18.51 17.24 17.51 17.87 17.98 18.21 17.72 18.68 1.3 0.0578
hsa-miR-193b* 27.03 26.74 26.67 26.42 25.97 26.56 27.79 28.64 28.21 28.00 26.18 28.62 27.80 28.45 28.01 29.03 2.3 0.0589
hsa-miR-146b-5p 16.11 15.98 16.81 15.35 15.29 14.79 15.72 16.44 16.67 16.20 16.47 16.59 17.21 17.05 16.23 18.16 2.1 0.0719
hsa-miR-30d 20.05 20.23 20.70 20.38 20.08 20.48 20.40 21.02 20.71 19.94 19.81 20.76 19.73 19.90 19.86 20.68 −1.3 0.0758
hsa-miR-744* 26.22 25.74 25.97 26.25 25.91 27.28 26.71 26.78 27.15 25.89 25.96 26.54 25.72 25.56 25.53 26.51 −1.5 0.0796
hsa-miR-18a 20.89 20.28 20.64 20.25 20.09 20.69 21.24 20.44 20.70 21.05 21.14 21.00 20.87 21.18 20.79 21.97 1.4 0.0825
hsa-miR-21 15.76 15.79 16.05 14.98 14.68 14.42 15.07 15.45 15.93 15.35 15.60 16.25 15.91 15.98 15.70 16.66 1.6 0.0825
hsa-miR-422a 24.87 24.01 24.74 24.78 24.01 24.30 23.57 24.44 24.92 23.44 23.89 23.80 23.43 23.23 22.88 24.08 −1.8 0.0825
hsa-miR-656 26.98 25.27 26.07 26.86 26.39 25.95 25.89 25.98 26.35 25.02 25.63 25.58 24.64 24.96 24.64 26.02 −1.9 0.0831
hsa-miR-22* 23.08 22.78 23.40 23.33 23.07 22.48 23.64 23.54 23.13 23.15 22.37 23.33 23.32 23.39 23.42 24.53 1.4 0.0845
hsa-miR-30c 15.71 14.74 14.86 14.83 14.55 14.76 14.88 15.15 15.57 14.49 14.55 14.92 14.51 14.55 14.17 15.17 −1.3 0.0947
hsa-miR-129-3p 26.03 26.55 25.28 25.31 26.12 25.96 26.07 25.54 26.79 24.73 24.34 24.95 24.48 25.00 24.19 25.34 −1.7 0.095

The table shows raw CT and fold change for all differentially expressed (adjusted p<0.05, above the bar) and miRNAs that showed a tendency to be statistically significant (p<0.1, below the bar) after applying multiple comparisons correction (Benjamini-Hochberg adjusted p values for false discovery rate) in the colon of twelve chronic SIV-infected macaques.